Diagnosis and Management of Childhood Apraxia of Speech using Dynamic Tactile and Temporal Cueing
Day 1: This workshop is offered free-of-charge to speech-language pathologists, speech-language pathology students, and parents of children with CAS.
Day 2: This workshop is open to 50 certified speech-language pathologists who attended Day 1 of the DTTC workshop. This workshop is offered free-of-charge to therapists working in not-for-profit organizations, including public schools. The registration fee for therapists working in for-profit organizations is $150.00.
Program Description Day 1: Diagnosis and Management of Childhood Apraxia of Speech (CAS) Using Dynamic Tactile and Temporal Cueing (DTTC)
This program will describe treatment of Childhood Apraxia of Speech (CAS) using evidence-based methods, particularly Dynamic Tactile and Temporal Cueing (DTTC). DTTC has been described as a motor-based treatment approach with preponderant evidence of positive treatment and generalization effects supported across independent research groups (Murray, et. al., 2014). DTTC was developed by Dr. Strand to treat children with moderate to severe CAS. This workshop will emphasize clinical thinking and decision-making as central to the processes of selecting and implementing any treatment approach for CAS. Several principles of motor learning are discussed in terms of incorporating them into DTTC. Rationale and procedures for treating children of different ages and severity levels using different treatment approaches will be described. Video demonstration of treatment techniques will help clinicians understand and apply methods in the clinical setting. Discussion will also emphasize the important role families play in treatment of CAS, including tools to help families understand and manage the disorder.
- List several principles of motor learning
- Describe treatment considerations when using principals of motor learning
- Describe the application of DTTC in treating children with CAS
- Describe cueing methods and selection of targets in treatment of CAS
Program Description Day 2: Advanced Clinical Decision-Making in the Treatment of CAS: Studies and Application of DTTC Methods
This workshop encourages speech-language pathologists to integrate and apply information presented in Day 1 of the workshop through case presentations/discussion and active participation of participants. This workshop is for clinicians who have developed an understanding of basic principles of CAS treatment, and are ready to practice application of that knowledge by writing diagnostic statement, selecting goals and targets, and practicing treatment techniques. Clinicians will be asked to read 3-4 articles prior to attending and to prepare for active participation in discussion.
- Apply knowledge of evidence-based CAS treatment to actual clinical cases in discussion, videos, and hands-on demonstration.
- Understand how to implement DTTC with various age groups, including very young children with suspected CAS and children with co-morbidities
- Identify appropriate, individualized therapy targets that facilitate motor learning and support functional communication and language development
Dr. Edythe Strand is Emeritus consultant, Division of Speech Pathology, Department of Neurology, Mayo Clinic and Emeritus Professor, Mayo College of Medicine. Dr. Strand’s research has focused on developmental, acquired and progressive apraxia of speech, and issues related to intelligibility and comprehensibility in degenerative dysarthria. She is an experienced clinician who has worked in the public schools, private practice, and hospital and clinic settings. Her primary clinical and research interests include assessment and treatment of children and adults with neurologic speech, language and voice disorders.
Dr. Strand’s publications include many articles and book chapters related to motor speech disorders. She frequently gives lectures on the assessment and treatment of motor speech disorders in children and adults, management of communication disorders in degenerative neurologic disease, and neuroanatomy. She is the co-author of the books: Management of Speech and Swallowing in Degenerative Disease; Clinical Management of Motor Speech Disorders in Children and Adults; and is Co-editor of the book, Clinical Management of Motor Speech Disorders in Children.
Dr. Strand is an ASHA fellow and has been awarded Honors of the Association of the American Speech-Language and Hearing Association.
Day 2 is limited to certified speech-language pathologists who attended Day 1
Dr. Strand’s participation is supported by the Once Upon a Time Foundation (honoraria, travel, and accommodations). There are no non-financial disclosures.